Although it appears that this protein is differently altered according to the tumour context, it has been demonstrated that aberrant RND3 expression may be the leading cause of tumour metastasis and chemotherapy resistance with a pro-tumourigenic role [56,57]. Here, RND3 is linked to neoplasm.